background
mani
respiratori
virus
disproportion
impact
elderli
likewis
advanc
age
correl
advers
diseas
outcom
follow
sever
acut
respiratori
syndrom
coronaviru
sarscov
infect
human
use
age
african
green
monkey
sarscov
infect
model
better
understand
agerel
mechan
increas
suscept
viral
respiratori
infect
nonhuman
primat
critic
translat
model
research
given
similar
human
immuneag
well
lung
structur
result
signific
ageand
infectiondepend
differ
observ
system
mucos
immun
compart
peripher
lymphocyt
specif
b
cell
significantli
lower
age
monkey
preand
postsarscov
infect
neutrophil
monocyt
number
impact
age
infect
statu
serum
proinflammatori
cytokin
similar
age
group
wherea
significantli
lower
level
detect
lung
sarscovinfect
age
monkey
either
day
post
infect
total
lung
leukocyt
number
rel
frequenc
cell
b
cell
macrophag
dendrit
cell
greatli
reduc
age
host
sarscov
infect
despit
high
level
chemoattract
mani
cell
age
lung
dendrit
cell
monocytesmacrophag
show
agedepend
differ
activ
chemokin
receptor
profil
cell
b
cell
respons
significantli
reduc
age
host
examin
viral
titer
significantli
higher
level
sarscov
detect
nasal
swab
earli
day
post
infect
age
compar
juvenil
monkey
viru
level
slightli
higher
age
anim
day
although
trend
higher
titer
respiratori
tissu
day
post
infect
reach
statist
signific
viru
clear
anim
day
regardless
age
conclus
studi
provid
uniqu
insight
sever
paramet
system
mucos
immun
respons
sarscov
infect
significantli
modul
age
immun
differ
may
contribut
defici
immun
function
observ
trend
higher
sarscov
replic
age
nonhuman
primat
viral
respiratori
infect
remain
predomin
caus
morbid
mortal
age
adult
elderli
heighten
suscept
infect
increas
risk
develop
sever
viralinduc
pulmonari
diseas
slower
recoveri
rate
sever
physiolog
paramet
thought
contribut
poor
outcom
infecti
diseas
elderli
popul
includ
age
immun
well
respiratori
system
almost
compon
immun
system
shown
undergo
ageassoci
restructur
greatli
impact
immun
function
declin
immun
function
age
also
result
reduc
vaccin
efficaci
enhanc
suscept
infect
elderli
ageassoci
alter
mucos
immun
system
thought
occur
distinct
time
distinct
manner
rel
system
immun
data
suggest
immunosenesc
may
occur
earlier
mucosa
system
immun
system
dramat
shift
age
proport
distinct
cell
subset
decreas
total
b
lymphocyt
advanc
age
also
associ
reduct
antigenspecif
iga
import
protect
antibodi
predominantli
local
mucosa
addit
immunolog
remodel
function
age
also
major
alter
respiratori
physiolog
age
lung
shown
undergo
structur
chang
includ
loss
static
recoil
forc
stiffen
chest
caviti
diminish
alveolar
surfac
area
ultim
result
reduc
vital
capac
addit
respiratori
muscl
strength
consist
declin
age
make
difficult
elderli
person
breath
even
suffer
respiratori
infect
limit
age
immun
respiratori
system
like
contribut
increas
mortal
observ
elderli
patient
year
old
sever
acut
respiratori
syndrom
coronaviru
sarscov
sarscov
epidem
result
human
infect
estim
mortal
rate
advanc
age
comorbid
significantli
associ
increas
risk
sarscov
relat
death
due
acut
respiratori
distress
syndrom
well
appreci
pulmonari
damag
sarscov
infect
caus
direct
viral
effect
well
immunopatholog
factor
howev
pathogen
mechan
vulner
age
popul
remain
poorli
defin
sever
age
anim
model
sarscov
infect
establish
evalu
respons
elucid
mechan
increas
sarscov
pathogen
age
host
recombin
infecti
clone
mous
passag
isol
sarscov
show
increas
sever
diseas
lethal
age
compar
young
mice
interestingli
age
young
host
show
similar
level
sarscov
replic
experiment
infect
thu
increas
acut
lung
injuri
sarscovinfect
age
anim
thought
relat
exuber
immun
respons
heighten
viralmedi
damag
howev
mani
aspect
elderli
immun
respons
may
differ
young
adult
still
unclear
furthermor
studi
repres
one
two
sarscov
infect
studi
age
nonhuman
primat
almost
age
sarscov
experi
date
conduct
mous
model
mouseadapt
viral
strain
although
murin
model
often
advantag
inform
nonhuman
primat
may
better
suit
studi
age
immun
respiratori
system
unlik
mice
nonhuman
primat
show
high
level
genet
homolog
human
inbr
longer
life
span
lung
structur
similar
human
laboratori
anim
importantli
studi
shown
nonhuman
primat
undergo
immun
senesc
similar
describ
human
aim
studi
determin
peripher
mucos
immun
respons
sarscov
infect
compar
age
juvenil
nonhuman
primat
host
determin
may
impact
viral
replic
level
report
sarscov
viru
titer
significantli
higher
nasal
caviti
age
monkey
day
post
infect
day
differ
titer
age
group
neglig
although
sarscov
viru
level
similar
age
juvenil
monkey
later
time
point
post
infect
signific
agedepend
differ
system
mucos
immun
respons
sarscov
evalu
impact
advanc
age
sever
sarscov
infect
age
juvenil
african
green
monkey
inocul
intranas
plaqueform
unit
pfu
sarscov
strain
mockinfect
sacrific
day
post
infect
dpi
age
anim
roughli
equival
year
old
human
n
time
point
post
infect
n
mockinfect
juvenil
anim
repres
year
old
n
juvenil
group
virolog
patholog
immunolog
data
juvenil
anim
previous
report
includ
agerel
comparison
examin
clinic
featur
anim
show
slight
initi
decreas
bodi
weight
sarscov
inocul
rebound
dpi
figur
anova
age
dpi
time
post
infect
age
signific
sourc
variat
fold
chang
bodi
weight
bodi
temperatur
howev
fluctuat
throughout
infect
time
cours
significantli
affect
age
infect
figur
anova
age
dpi
sarscov
titer
measur
nasal
swab
sever
respiratori
tissu
plaqu
assay
replic
viru
recov
nasal
swab
age
anim
dpi
contrast
one
juvenil
anim
detect
viru
earli
time
point
figur
anova
age
dpi
day
time
point
sarscov
replic
significantli
differ
dpi
viru
level
slightli
higher
age
anim
titer
remain
similar
age
group
day
signific
agedepend
differ
sarscov
level
observ
standard
collect
respiratori
tissu
dpi
figur
anova
age
howev
level
viru
tend
higher
tissu
age
compar
juvenil
anim
except
proxim
portion
right
caudal
lung
lobe
viru
detect
sampl
collect
either
age
group
dpi
determin
advanc
age
correl
increas
sever
lung
patholog
comprehens
histolog
analysi
respiratori
tract
follow
sarscov
infect
conduct
age
juvenil
anim
dpi
sarscovinduc
histolog
chang
lung
higher
incid
age
compar
juvenil
monkey
tabl
chang
includ
perivascular
cuf
inflammatori
cell
alveol
interstiti
pneumonia
howev
venou
thrombosi
observ
juvenil
anim
dpi
wherea
venou
thrombosi
detect
age
anim
either
time
point
sever
lung
patholog
slightli
higher
age
compar
juvenil
anim
dpi
dpi
juvenil
anim
exhibit
higher
incid
sever
histolog
chang
mark
increas
incid
interstiti
pneumonia
observ
juvenil
age
monkey
dpi
juvenil
versu
age
taken
togeth
histolog
chang
associ
sarscovinduc
interstiti
pneumonia
slightli
lower
incid
sever
age
compar
juvenil
host
determin
agespecif
differ
immun
activ
follow
sarscov
infect
system
inflammatori
respons
compar
age
juvenil
anim
peripher
blood
draw
prior
day
use
monitor
circul
immun
cell
cytokin
profil
total
white
blood
cell
count
age
monkey
lower
juvenil
counterpart
preand
post
sarscov
infect
time
point
figur
anova
age
dpi
examin
specif
leukocyt
popul
neutrophil
monocyt
number
significantli
vari
sarscov
infect
unaffect
age
figur
c
anova
age
dpi
contrast
age
signific
sourc
variat
lymphocyt
number
reduc
cell
b
cell
peripher
blood
age
compar
juvenil
anim
figur
f
anova
age
dpi
serum
cytokin
profil
sarscov
infect
age
juvenil
monkey
defin
use
beadbas
protein
array
focus
inflammatori
cytokin
chemokin
associ
antivir
respons
tabl
compar
age
juvenil
anim
level
ifngamma
similar
trend
higher
age
monkey
wherea
higher
juvenil
although
reach
statist
signific
anova
age
dpi
receptor
agonist
baselin
level
day
significantli
elev
serum
age
anim
juvenil
counterpart
anova
age
dpi
bonferroni
posttest
expect
experi
use
noninbr
anim
variat
serum
cytokin
rel
high
particularli
age
anim
consist
previous
publish
age
nonhuman
primat
studi
determin
mucos
cytokin
sarscov
infect
compar
system
respons
age
may
impact
mucos
cytokin
express
inflammatori
protein
profil
evalu
beadbas
array
standardizedcollect
lung
tissu
proxim
portion
right
caudal
lobe
focu
inflammatori
cytokin
thought
play
role
antivir
immun
contrast
higher
cytokin
trend
serum
age
anim
cytokin
lung
often
lower
age
compar
juvenil
monkey
proinflammatori
cytokin
significantli
lower
age
compar
juvenil
anim
dpi
respect
figur
b
unpair
student
ttest
age
monkey
show
significantli
lower
level
day
lower
dpi
compar
juvenil
figur
unpair
student
ttest
also
trend
decreas
level
lung
age
versu
juvenil
monkey
although
reach
statist
signific
figur
unlik
juvenil
anim
interferongamma
level
detect
age
lung
sampl
data
shown
gener
cytokin
tend
increas
sarscov
infect
juvenil
sever
averag
grade
group
normal
minim
mild
moder
mark
incid
percentag
group
affect
monkey
wherea
level
age
group
show
infectioninduc
increas
chemokin
play
critic
role
coordin
migrat
leukocyt
lung
trigger
effect
immun
respons
viral
pathogen
chemokin
milieu
lung
follow
sarscov
infect
evalu
age
juvenil
anim
target
protein
array
unlik
data
proinflammatori
cytokin
lung
sever
chemokin
show
increas
express
sarscov
infect
detect
higher
level
age
compar
juvenil
host
cell
chemoattract
elev
age
group
sarscov
infect
figur
howev
level
age
lung
reach
magnitud
juvenil
significantli
lower
comparison
dpi
unpair
student
ttest
contrast
anoth
activ
cell
chemoattract
significantli
higher
age
compar
juvenil
anim
throughout
sarscov
infect
period
figur
unpair
student
ttest
b
cell
chemoattract
dramat
lower
age
compar
juvenil
anim
regardless
infect
statu
wherea
known
dendrit
cell
dc
chemoattract
much
higher
mock
sarscov
infect
age
anim
figur
f
unpair
student
ttest
determin
age
impact
kinet
magnitud
mucos
inflamm
respons
sarscov
immun
cell
popul
quantifi
character
flow
cytometri
standard
collect
lung
tissu
proxim
portion
right
caudal
lobe
lung
drain
lymph
node
number
total
lung
leukocyt
per
gram
lung
tissu
similar
pi
significantli
lower
age
compar
juvenil
anim
dpi
figur
unpair
student
ttest
frequenc
distinct
lung
leukocyt
popul
includ
macrophag
hladr
dendrit
cell
dc
lymphocyt
b
cell
differ
two
age
group
sarscov
infect
figur
e
gate
strategi
shown
addit
file
figur
addit
file
figur
averag
valu
summar
addit
file
tabl
frequenc
lung
macrophag
lower
age
compar
juvenil
anim
mock
sarscov
infect
reach
signific
dpi
figur
unpair
student
ttest
proport
lung
dc
also
significantli
lower
age
anim
infect
time
point
examin
figur
unpair
student
ttest
although
lung
b
cell
frequenc
increas
infect
juvenil
anim
increas
observ
age
monkey
infect
time
point
significantli
lower
cell
b
cell
frequenc
detect
age
monkey
figur
e
unpair
student
ttest
contrast
lung
agedepend
differ
leukocyt
number
frequenc
b
cell
note
tracheobronchi
lymph
node
figur
h
unpair
student
ttest
assess
agespecif
differ
immun
sarscov
infect
activ
statu
chemokin
receptor
profil
assess
monocyt
macrophag
dc
cell
peripher
monocyt
defin
flow
cytometri
use
hladr
express
dc
see
peripher
blood
monocyt
dc
gate
strategi
addit
file
figur
express
activ
marker
show
signific
agedepend
differ
monocyt
lung
macrophag
dc
popul
significantli
less
express
age
sarscovinfect
anim
tabl
anova
addit
file
figur
addit
file
figur
also
examin
peripher
monocyt
dc
cell
receptor
express
chemokin
found
highest
concentr
age
lung
receptor
age
monocyt
show
reduc
similar
level
compar
juvenil
counterpart
tabl
anova
age
dpi
frequenc
cell
express
anoth
receptor
significantli
impact
age
receptor
significantli
regul
age
sarscov
infect
peripher
blood
dc
tabl
anova
age
dpi
cell
respons
sarscov
infect
evalu
peripher
blood
lung
tracheobronchi
lymph
node
flow
cytometr
analysi
see
gate
strategi
addit
file
figur
addit
file
figur
although
agedepend
differ
observ
frequenc
cell
peripher
blood
significantli
lower
level
cell
lung
lymph
node
age
anim
sarscov
infect
figur
c
unpair
student
ttest
similar
trend
observ
prolifer
cytotox
granzym
b
cell
lower
lung
lymph
node
age
compar
juvenil
counterpart
infect
time
point
figur
unpair
student
ttest
howev
granzym
b
cell
level
tend
higher
peripher
blood
age
compar
juvenil
anim
reach
signific
dpi
figur
unpair
student
ttest
determin
b
cell
respons
sarscov
impact
age
antisarscov
antibodi
evalu
serum
lung
serum
neutral
assay
reveal
increas
antibodi
juvenil
anim
sarscov
infect
earli
dpi
figur
anova
age
dpi
contrast
sarscov
neutral
antibodi
detect
dpi
age
monkey
antibodi
titer
significantli
lower
compar
juvenil
antisarscov
igg
iga
antibodi
lung
tissu
homogen
determin
elisa
lung
antisarscov
igg
detect
age
juvenil
anim
dpi
although
titer
figur
percent
frequenc
summar
addit
file
tabl
p
p
unpair
student
ttest
compar
age
group
p
compar
infect
time
point
increas
juvenil
lung
day
increas
antisar
cov
igg
titer
observ
age
anim
figur
signific
unpair
student
test
antisarscov
iga
titer
significantli
lower
age
compar
juvenil
anim
dpi
averag
titer
lower
age
host
figur
unpair
student
test
elderli
consid
fastestgrow
demograph
unit
state
expect
make
popul
well
recogn
elderli
individu
incur
enhanc
sever
respiratori
infect
accord
center
diseas
control
prevent
estim
flurel
death
unit
state
occur
peopl
older
sarscov
emerg
human
popul
elderli
also
disproportion
affect
individu
make
total
fatal
case
poor
understand
relationship
age
host
respons
respiratori
viru
infect
understand
biolog
chang
occur
age
human
limit
studi
peripher
blood
may
reflect
immun
dynam
respiratori
tract
studi
aim
gain
insight
kinet
magnitud
system
mucos
immun
respons
sarscov
infect
age
nonhuman
primat
import
translat
model
immuneag
research
significantli
higher
level
viral
replic
nasal
secret
age
monkey
compar
juvenil
anim
dpi
unexpect
age
sarscov
studi
detect
agedepend
differ
infect
level
higher
sarscov
titer
may
miss
previou
age
nonhuman
primat
experi
dpi
earliest
sampl
time
point
day
studi
age
juvenil
infect
level
similar
although
certain
measur
replic
viru
viru
deliv
inoculum
dramat
differ
amount
recov
suggest
age
nasal
epithelium
may
support
higher
level
sarscov
nasal
caviti
drainag
mechan
impair
age
host
despit
earli
ageassoci
differ
viral
shed
mucos
site
dpi
level
sarscov
respiratori
tract
tissu
slightli
higher
age
monkey
similar
previou
report
viru
recov
anim
dpi
suggest
kinet
viral
clearanc
may
similar
age
group
howev
addit
sampl
day
post
infect
would
necessari
confirm
observ
averag
frequenc
chemokin
receptor
activ
marker
posit
cell
total
perhipher
blood
lung
leukocyt
monocyt
hladr
peripher
blood
dendrit
cell
dc
cell
lung
macrophag
defin
hladr
lung
dc
gate
strategi
show
addit
file
figur
addit
file
figur
addit
file
figur
statist
result
anova
age
day
post
infect
dpi
indic
right
asterisk
denot
degre
sigrific
p
p
p
age
monkey
studi
exhibit
significantli
decreas
total
white
blood
cell
count
consist
invers
correl
wbc
age
observ
steadi
state
sever
rhesu
human
studi
leukocyt
popul
blood
lymphocyt
number
dramat
affect
age
flow
cytometr
result
show
significantli
reduc
cell
b
cell
age
compar
juvenil
monkey
contrast
peripher
cytokin
respons
show
minim
agerel
differ
sarscov
infect
may
relat
high
variabl
particularli
age
group
consist
previou
report
elderli
rhesu
monkey
regard
mucos
inflammatori
reaction
proinflammatori
cytokin
significantli
lower
lung
sarscovinfect
age
anim
either
day
post
infect
particular
reduc
level
line
recent
report
impair
inflammasom
function
elderli
mice
influenza
infect
low
cytokin
respons
age
monkey
may
also
reflect
reduc
total
inflammatori
cell
number
found
lung
age
compar
juvenil
anim
cell
cytokin
evalu
adjac
lung
region
data
consist
exacerb
acut
inflammatori
respons
shown
promot
diseas
pathogenesi
age
sarscovinfect
mous
model
sampl
earlier
day
post
infect
lung
increas
inflamm
age
monkey
may
miss
sampl
schedul
may
also
preclud
collect
optim
inflammatori
respons
time
point
biphas
pattern
occur
wave
day
post
infect
mouseadapt
sarscov
strain
describ
age
rodent
figur
p
p
p
p
unpair
student
ttest
compar
age
group
addit
differ
find
age
mice
result
also
dissimilar
previous
report
age
nonhuman
primat
sarscov
studi
smit
et
al
observ
stronger
innat
immun
respons
sever
patholog
age
monkey
compar
result
sever
experiment
design
aspect
take
consider
beyond
differ
dose
rout
sarscov
infect
first
cynomolg
macaqu
use
previou
studi
wherea
sarscov
infect
model
util
african
green
monkey
addit
time
lung
sampl
collect
differ
two
studi
day
assess
cynomolg
macaqu
day
post
infect
evalu
studi
furthermor
standard
lung
collect
scheme
use
immunolog
patholog
analysi
give
comprehens
perspect
wherea
studi
assess
gene
chang
specif
region
high
sarscov
replic
despit
major
differ
studi
design
sever
result
compar
includ
similar
sarscov
viral
titer
age
juvenil
lung
later
infect
time
point
day
addit
sever
chemokin
includ
significantli
increas
lung
sarscovinfect
age
monkey
consist
find
elev
chemokin
signal
gene
age
lung
cynomolg
macaqu
sarscov
infect
microarray
immun
senesc
shown
impact
innat
well
adapt
branch
immun
system
contribut
diminish
immun
observ
elderli
examin
kinet
lung
lymph
node
cell
expans
andor
traffick
follow
sarscov
infect
found
significantli
reduc
lung
macrophag
dc
cell
b
cell
age
anim
rel
juvenil
counterpart
fewer
lung
macrophag
dc
age
anim
frequenc
costimulatori
cell
also
significantli
reduc
contrast
lymph
node
reaction
show
agespecif
differ
interestingli
although
lung
leukocyt
number
reduc
age
monkey
disproportion
high
level
chemokin
capabl
recruit
cell
lung
prompt
examin
express
correspond
ligandbind
receptor
peripher
blood
leukocyt
determin
agerel
differ
migratori
capac
cell
lung
receptor
found
significantli
reduc
frequenc
monocyt
age
anim
similar
frequenc
cell
age
group
frequenc
age
dc
express
receptor
show
dramat
agespecif
reduct
reason
given
predominantli
express
immatur
dc
may
reflect
reduct
cell
age
anim
observ
differ
lung
chemokin
ligand
receptor
express
may
reflect
agespecif
modul
leukocyt
traffick
lung
although
confirm
observ
mechanist
vitro
experi
previou
studi
shown
dc
acquir
older
individu
display
significantli
impair
abil
migrat
respons
chemokin
also
examin
agespecif
differ
b
cell
respons
sarscov
infect
system
mucos
site
surprisingli
proport
cell
lung
lymph
node
significantli
reduc
age
compar
juvenil
anim
sarscov
infect
correspond
significantli
lower
level
cell
prolifer
site
age
anim
well
interestingli
frequenc
cytotox
enzym
posit
granzym
b
cell
higher
dpi
peripheri
age
compar
juvenil
anim
howev
age
peripher
granzym
cell
frequenc
remain
unchang
sarscov
infect
wherea
juvenil
cytotox
cell
show
infectioninduc
fluctuat
contrast
peripher
blood
lung
lymph
node
age
anim
lower
frequenc
granzym
cell
compar
juvenil
anim
dpi
humor
respons
also
greatli
reduc
age
sarscovinfect
monkey
significantli
reduc
serum
neutral
antibodi
mucos
antisarscov
iga
age
host
limit
antibodi
respons
may
relat
dramat
reduc
lung
peripher
b
lymphocyt
popul
observ
age
monkey
consist
report
elderli
human
despit
defici
observ
age
adapt
respons
viral
titer
significantli
higher
age
monkey
day
post
infect
suggest
innat
compensatori
immun
respons
suffici
viral
control
age
monkey
serv
support
minim
involv
cytotox
cell
neutral
antibodi
sarscov
clearanc
demonstr
mous
deplet
model
taken
togeth
data
indic
system
mucos
immun
sarscov
infect
differ
age
compar
juvenil
host
knowledg
import
consid
design
effect
intervent
strategi
sarscov
potenti
respiratori
infect
experiment
result
support
futur
mechanist
studi
identifi
adjunct
strategi
capabl
overcom
immun
deficit
age
airway
mucosa
may
ultim
translat
novel
approach
enhanc
efficaci
vaccin
respiratori
pathogen
elderli
popul
studi
found
viral
titer
age
compar
juvenil
monkey
significantli
higher
earli
infect
level
becam
compar
age
group
later
infect
time
point
observ
signific
age
infectiondepend
differ
system
mucos
immun
compart
dramat
chang
cytokin
level
leukocyt
frequenc
lung
compar
peripher
blood
tracheobronchi
lymph
node
regard
exacerb
sarscov
respons
previous
report
age
nonhuman
primat
observ
enhanc
host
immun
patholog
age
monkey
instead
detect
less
inflammatori
cytokin
total
lung
leukocyt
well
reduc
adapt
respons
increas
age
although
result
discrep
studi
indic
pulmonari
immun
intrins
differ
age
compar
juvenil
host
warrant
explor
given
import
implic
vaccin
therapeut
design
elderli
procedur
conduct
protocol
approv
institut
anim
care
use
committe
iacuc
lovelac
respiratori
research
institut
lrri
facil
accredit
associ
assess
accredit
laboratori
anim
care
intern
aaalac
guidelin
nonhuman
primat
describ
guid
care
use
laboratori
anim
nation
research
council
strictli
adher
anim
use
studi
adult
african
green
monkey
obtain
barbado
primat
research
centr
barbado
west
indi
global
research
suppli
llc
reno
nv
class
b
usda
licens
anim
dealer
permit
import
anim
new
mexico
acquir
fish
wildlif
servic
lrri
age
african
green
monkey
determin
yr
old
remain
subject
young
adult
year
old
addit
two
femal
african
green
monkey
yr
yr
acquir
wake
forest
univers
primat
center
medic
center
boulevard
winstonsalem
estim
differ
relat
age
human
rhesu
macaqu
age
african
green
monkey
studi
expect
repres
approxim
year
old
human
juvenil
african
green
monkey
correspond
year
old
rhesustohuman
age
convers
use
given
estim
age
convers
well
establish
african
green
monkey
genet
similar
two
old
world
monkey
speci
belong
super
famili
cercopithecoidea
random
group
assign
age
monkey
studi
perform
provanti
integr
preclin
softwar
instem
life
scienc
system
ltd
monkey
quarantin
week
prior
studi
test
tuberculosi
anim
given
subcutan
microchip
identif
temperatur
measur
implant
temperatur
transpond
handheld
wireless
reader
system
bio
medic
data
system
inc
seaford
delawar
infecti
portion
studi
anim
individu
hous
indoor
stainless
steel
cage
wire
mesh
bottom
temperatur
humid
rang
control
along
h
light
dark
cycl
anim
also
given
environment
enrich
includ
toy
twice
per
day
tap
water
institut
water
system
avail
ad
libitum
anim
fed
twice
day
harlan
teklad
certifi
monkey
diet
biscuitskg
bodi
weight
banana
appl
enrich
time
per
week
sarscov
strain
provid
dr
leo
poon
depart
microbiolog
univers
hong
kong
hong
kong
china
viral
stock
gener
vero
cell
experiment
infect
plaqueform
unit
pfu
sarscov
instil
intranas
conduct
previous
report
monkey
examin
train
laboratori
anim
technician
twice
per
day
least
h
apart
day
studi
paramet
includ
appetit
appear
activ
stool
postur
neurolog
sign
respir
ocular
discharg
nasal
discharg
onset
abnorm
clinic
sign
document
score
sheet
complet
day
begin
date
anim
fell
ill
euthanasia
allevi
suffer
conduct
base
clinic
observ
score
sheet
consult
staff
veterinarian
anim
sacrif
dpi
n
juvenil
n
age
anim
time
point
intraven
overdos
virbac
ah
inc
fort
worth
tx
virusfre
cell
cultur
medium
use
inocul
mockinfect
control
n
juvenil
n
age
immunolog
virolog
patholog
data
juvenil
anim
previous
report
includ
manuscript
comparison
age
monkey
viru
titer
measur
plaqu
assay
appli
serial
dilut
homogen
tissu
supernat
onto
vero
cell
monolay
previous
describ
measur
sarscov
neutral
antibodi
serum
sampl
serial
dilut
incub
pfuml
sarscov
overnight
inocul
onto
vero
cell
titer
express
reciproc
highest
dilut
cytopath
effect
complet
inhibit
standard
collect
lung
tissu
proxim
portion
right
caudal
lobe
process
singlecel
suspens
flow
cytometri
note
sampl
flow
cytometr
analysi
cytokin
protein
evalu
acquir
adjac
tissu
region
singl
cell
suspens
prepar
detail
briefli
mechan
enzymat
digest
liberas
roch
pleasanton
ca
dnase
sigma
st
loui
mo
solut
perform
prior
overlay
sampl
percol
sigma
gradient
min
g
brake
tracheobronchi
lymph
node
collect
standard
manner
region
size
tissu
collect
anim
singlecel
suspens
made
mechan
disrupt
peripher
blood
mononuclear
cell
pbmc
isol
heparin
blood
ficolhypaqu
sigma
gradient
previous
report
flow
cytometr
analysi
conduct
previous
frozen
pbmc
lung
lymph
node
leukocyt
follow
antibodi
use
stain
panel
clone
clone
clone
clone
clone
clone
santa
cruz
biotechnolog
dalla
tx
clone
granzym
b
clone
invitrogen
carlsbad
ca
hladr
clone
clone
clone
clone
clone
clone
clone
r
system
minneapoli
mn
conjug
fluorochrom
fitc
pe
percp
apc
bd
bioscienc
san
jose
ca
unless
specifi
intracellular
antigen
bd
fac
lyse
permeabil
solut
use
accord
manufactur
instruct
assess
given
downregul
marker
african
green
monkey
lymphocyt
antibodystain
sampl
fix
hr
paraformaldehyd
fb
phosphat
buffer
salin
sampl
data
acquir
facscalibur
facscanto
flow
cytomet
instrument
bd
bioscienc
data
file
analyz
util
flowjo
softwar
treestar
medford
flow
cytometr
analysi
within
one
experi
gate
appli
sampl
ident
see
gate
strategi
addit
file
figur
addit
file
figur
addit
file
figur
appropri
possibl
similar
gate
use
across
two
differ
experi
juvenil
age
sampl
howev
base
chang
flow
cytomet
set
fluoresc
minu
one
control
gate
adjust
two
experi
marker
chosen
character
specif
leukocyt
subset
pbmc
lymph
node
lung
base
previous
publish
studi
human
nonhuman
primat
lung
tissu
acquir
standard
collect
scheme
section
proxim
right
caudal
lobe
divid
two
portion
one
homogen
assess
cytokin
antibodi
viru
lung
leukocyt
isol
portion
flow
cytometri
see
previou
section
homogen
volum
rpmi
media
gibco
life
techolog
grand
island
ny
equal
lung
tissu
weight
ad
sarscov
igg
iga
antibodi
measur
elisa
detail
briefli
elisa
plate
coat
purifi
recombin
sarscov
protein
carbonateco
buffer
protein
obtain
nih
biodefens
emerg
infect
research
resourc
repositori
nonspecif
bind
block
powerblock
biogenex
san
ramon
ca
start
dilut
serial
dilut
lung
tissu
homogen
supernat
clarifi
centrifug
incub
sprotein
coat
plate
overnight
antimonkey
igg
iga
hrpconjug
antibodi
kpl
inc
gaithersburg
md
appli
follow
substrat
develop
abt
microwel
peroxidas
substrat
system
kpl
absorb
read
nm
use
thermo
electron
corpor
plate
reader
thermo
electron
corpor
houston
tx
data
acquir
ascent
softwar
ascent
softwar
london
uk
elisa
antibodi
titer
record
sampl
reciproc
highest
dilut
optic
densiti
od
read
sprotein
bound
well
least
twofold
higher
nonfat
milk
control
od
highest
titer
chosen
also
fall
within
linear
rang
serial
dilut
cytokin
chemokin
protein
measur
lung
tissu
homogen
serum
use
human
nonhuman
primat
multiplex
beadbas
array
kit
millipor
billerica
assay
perform
accord
manufactur
instruct
overnight
incub
sampl
antibodyimmobil
bead
data
collect
bioplex
system
biorad
hercul
ca
weight
logist
curvefit
method
use
calcul
concentr
individu
analyt
measur
perform
duplic
data
report
pgml
undetect
serum
either
age
group
tnfalpha
level
detect
lung
tissu
homogen
sampl
tissu
histopatholog
perform
previous
report
standard
manner
random
assess
organ
fix
paraformaldehyd
solut
prior
embed
paraffin
thick
tissu
section
stain
hematoxylin
eosin
examin
microscop
board
certifi
veterinari
pathologist
histolog
lesion
grade
sever
normal
minim
mild
moder
mark
distribut
focal
multifoc
diffus
infect
age
differ
evalu
use
anova
bonferroni
posttest
twotail
student
ttest
appropri
data
statist
evalu
log
transform
analyz
graphpad
prism
softwar
graphpad
la
jolla
ca
p
valu
less
consid
statist
signific
addit
file
figur
gate
strategi
analysi
extracellular
marker
b
cell
repres
gate
strategi
flow
cytometr
analysi
lung
lymph
node
pbmc
illustr
base
pbmc
age
monkey
first
lymphocyt
gate
base
forward
side
scatter
appli
percent
frequenc
total
cell
indic
plot
fscssc
cell
subsequ
gate
base
express
cell
evalu
coexpress
cell
marker
express
b
lymphocyt
gate
base
express
absenc
percent
frequenc
total
gate
lymphocyt
base
fscssc
gate
indic
plot
addit
file
figur
gate
strategi
analysi
intracellular
marker
gate
strategi
flow
cytometr
analysi
macrophag
dendrit
cell
cell
intracellular
marker
use
shown
use
repres
lung
sampl
age
anim
leukocyt
first
gate
forward
side
scatter
percent
frequenc
total
cell
indic
plot
fscssc
cell
subsequ
gate
hladr
macrophag
dendrit
cell
dc
macrophag
defin
hladr
evalu
express
neg
hladr
cell
gate
posit
defin
dc
also
evalu
express
cell
defin
assess
express
intracellular
antigen
granzym
b
percent
frequenc
total
gate
leukocyt
base
fscssc
indic
plot
addit
file
tabl
rel
frequenc
leukocyt
popul
lung
lymph
node
sarscov
infect
addit
file
figur
gate
strategi
peripher
monocyt
dendrit
cell
gate
strategi
monocyt
dc
peripher
blood
depict
use
repres
age
pbmc
sampl
cell
first
gate
base
forward
side
scatter
percent
frequenc
total
cell
indic
plot
subsequ
gate
hladr
express
monocyt
defin
hladr
monocyt
subsequ
evalu
